Skip to content
Directory

Treatment, Medication & Supplement Directory

A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.

Directory explains “what it is.”Guides explain how owners can discuss, use, monitor, or prepare for a treatment option with veterinary guidance.
Filtered (2)
Filtered (2)
Filter

Filter

2 directory found

Type
See more See less
Species
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
Product Family
See more See less
Regulatory Status
See more See less
Region / Availability
See more See less
Search
Apply(2) Reset
Show (2)
Cancel
Apply(2) Reset
2 entriesShowing 1–2
Veterinarian reviewing an immune pathway concept and an unbranded biologic treatment with a dog caregiverNamed profile Oncept Canine Melanoma Vaccine, DNA: USDA-Licensed Therapeutic BiologicRepresentative category illustration – no product packaging is shown.
Immunotherapy · Oncept · Dogs · After Targeted Therapy · Before Targeted Therapy · During Targeted Therapy · Manufacturer Information

Oncept Canine Melanoma Vaccine, DNA: USDA-Licensed Therapeutic Biologic

Oncept is a USDA-listed canine melanoma DNA biologic; license status, specialist access, intended setting, evidence limitations, and cost require current review.

Read more
Veterinarian reviewing an immune pathway concept and an unbranded biologic treatment with a dog caregiverNamed profile Gilvetmab: Canine PD-1 Immunotherapy and Conditional-Licence ProfileRepresentative category illustration – no product packaging is shown.
Immunotherapy · Prescription Drug · Gilvetmab · Dogs · During Targeted Therapy · New Diagnosis · Published Study

Gilvetmab: Canine PD-1 Immunotherapy and Conditional-Licence Profile

gilvetmab is covered as caninized anti-pd-1 monoclonal antibody immune-checkpoint inhibitor, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more